Teleflex 유동비율
Teleflex(TFX)의 유동비율는 2026년 3월 30일 기준 2.27입니다.전년도에 유동비율는 2.32이었습니다 — -2.33%(낮음)의 변화입니다.
Get this data via API
Financial Data API
유동비율
2.27
YoY
-2.33%
마지막 업데이트:
Teleflex의 유동비율는 2026 2.27 입니다. Teleflex의 유동비율는 2025 2.32 였습니다. 따라서 전년에 비해 -2.33% 낮음하게 감소합니다.
Access this data via the Eulerpool API
Teleflex 주식 분석
Teleflex는 무엇을 하나요? Teleflex Inc. is a global company founded in 1943. The company is headquartered in Wayne, Pennsylvania, USA and operates in over 40 countries worldwide. It is a leading provider of medical devices, instruments, and accessories for various applications in clinical practice and patient care.
The business model of Teleflex is based on the manufacturing and marketing of medical devices and instruments, particularly in the areas of anesthesia, vascular access, interventional medicine, pulmonary and thoracic surgery, urological care, cardiovascular diagnostics, and surgery. The company works closely with medical professionals and clinicians to develop high-quality products that meet the needs of patients and doctors.
Teleflex is divided into several business segments, including angiography/diagnostics, anesthesia, oncology, vascular intervention, pulmonology, surgery, and urology. Each of these segments offers a wide range of products and solutions specifically tailored to the needs of doctors and patients.
In the angiography/diagnostics segment, Teleflex offers a variety of products that can be used for the diagnosis and treatment of cardiovascular diseases and other medical conditions. These include catheters, guide wires, and sheaths.
The anesthesia segment of Teleflex includes products such as ventilation bags, endotracheal tubes, and nebulizer systems. These products are essential for the successful performance of anesthesia procedures and can help doctors save valuable time and resources.
The oncology segment of Teleflex offers a wide range of products specifically designed for the treatment of cancer patients. These include catheter-based systems that can facilitate the administration of drugs and other therapies.
With the vascular intervention segment, Teleflex offers a comprehensive range of products and solutions specifically designed for the treatment of vascular diseases. These include balloon catheters, stents, and sheaths.
The pulmonology segment of Teleflex offers products aimed at facilitating breathing and improving the quality of life for patients with chronic respiratory diseases. These include oxygen concentrators, tracheal tubes, and ventilators.
The surgical segment of Teleflex offers a variety of solutions for performing surgical procedures, including surgical instruments, sutures, and wound care materials.
The urology segment of Teleflex offers a wide range of products specifically designed for use in urology. These include catheters, wires, and stents.
Teleflex is a leading company in the medical technology industry that specializes in the development and marketing of products that improve patients' quality of life and facilitate the work of doctors. With its innovative solutions and a focus on providing the best possible customer service and patient safety, Teleflex has taken on a significant role in the industry and will continue to be an important provider in this market in the future. Teleflex는 Eulerpool에서 가장 인기 있는 회사 중 하나입니다.
Teleflex 주식에 대한 자주 묻는 질문
유동비율의 Teleflex는 2.32 2.27였습니다
Access this data via the Eulerpool API
재무 레버리지 — Teleflex
모든 카테고리
밸류에이션
손익계산서
대차대조표
현금 흐름
수익성
재무 레버리지
성장
- 매출성장율
- 매출 3년 CAGR
- 매출 5년 CAGR
- 매출 10년 CAGR
- 순이익성장율
- 주당순이익성장율
- EBIT성장율
- EBIT 3년 CAGR
- EBIT 5년 CAGR
- EBIT 10년 CAGR
- 배당성장율
- 잉여현금흐름성장율
- 순자산가치성장율
- 순이익 3년 CAGR
- 순이익 5년 CAGR
- 순이익 10년 CAGR
- EPS 3년 CAGR
- EPS 5년 CAGR
- EBITDA 전년 대비 성장
- EBITDA 3년 CAGR
- EBITDA 5년 CAGR
- 총이익 성장
- OCF 전년 대비 성장
- 직원 성장
- 배당금 3년 CAGR
- 배당금 5년 CAGR
- 배당금 10년 CAGR
- 자산 성장
- 자본 성장
- 차입금 성장
- CapEx 성장
- FCF 3년 CAGR
- FCF 5년 CAGR
- 시가총액 성장
- 주식수 성장